Table 1.

Genotype distributions of studied genetic variants in OFC and healthy patients.

Genetic Variant	N (total)	Genotype	Study Group n = 209	Control Group n = 418
rs987525		AA	13 (7.22%)	14 (4.06%)
	525	AC	79 (43.89%)	99 (28.70%)
		CC	88 (48.89%)	232 (67.25%)
rs590223		AA	76 (46.06%)	133 (45.24%)
	459	AG	71 (43.03%)	138 (46.94%)
		GG	18 (10.91%)	23 (7.82%)
rs522616	494	AA	125 (65.10%)	207 (68.54%)
		AG	61 (31.77%)	83 (27.48%)
		GG	6 (3.13%)	12 (3.97%)
rs4714384	552	CC	20 (10.47%)	30 (8.31%)
		CT	80 (41.88%)	188 (52.08%)
		TT	91 (47.64%)	143 (39.61%)